Overview

A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors

Status:
Completed
Trial end date:
2017-06-22
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the effects of talazoparib on cardiac repolarization in patients with advanced solid tumors with no available standard treatment options.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Collaborator:
Medivation, Inc.
Treatments:
Talazoparib